Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pharm Biol ; 55(1): 2153-2160, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29025319

RESUMO

CONTEXT: Salvia przewalskii Maxim. (Lamiaceae) is a Chinese herbal medicine that has long been used for the treatment of cardiovascular disease. OBJECTIVE: The study investigated the therapeutic efficacy of S. przewalskii total phenolic acid extract (SPE) on immune complex glomerulonephritis (ICG) in rats. MATERIALS AND METHODS: Sixty-two Wistar rats were randomized into six groups. ICG was induced in all groups except normal control group. SPE was administered intragastrically at 24 h intervals for 40 consecutive days. Urine protein (UP), total serum protein (TSP), serum albumin (SA), serum cholesterol (SC) and serum urea nitrogen (SUN) were measured one day before, on day 20 and 40 after SPE administration. On day 40 after SPE administration, the kidneys were removed and prepared into pathologic sections. In addition, kidney wet mass was measured for calculating the kidney wet mass coefficient (KWMC). RESULTS: UP excretion was reduced significantly on day 20 after SPE administration in all three SPE groups as compared with that in medium group, and this effect was observable continuously until 40 days after SPE administration. Compared with medium group, TSP and SA were increased in all three SPE groups after 40 days treatment, while SC and SUN were decreased. KWMC was decreased significantly in 100 mg/kg SPE group after 40 days treatment compared with that in medium group. Histopathologic analyses showed that renal inflammatory infiltration and kidney intumesce were alleviated in all three SPE groups. CONCLUSIONS: SPE may be a potential therapeutic drug for glomerulonephritis.


Assuntos
Glomerulonefrite/tratamento farmacológico , Hidroxibenzoatos/uso terapêutico , Doenças do Complexo Imune/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Salvia , Animais , Glomerulonefrite/metabolismo , Doenças do Complexo Imune/metabolismo , Extratos Vegetais/isolamento & purificação , Raízes de Plantas , Distribuição Aleatória , Ratos , Ratos Wistar , Rizoma , Resultado do Tratamento
2.
Prostaglandins ; 38(3): 385-96, 1989 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2528785

RESUMO

In contrast to animals on a beef fat-supplemented diet (BFD), animals maintained on a fish fat-supplemented diet (FFD) incorporate increased amounts of eicosapentaenoic acid (EPA) into membrane phospholipids. Generation of lipid mediators from such tissues favors the formation of compounds with less pro-inflammatory activity than are derived from tissues poor in EPA. Nevertheless, the FFD has not had a uniformly beneficial effect on animal models of inflammatory diseases. We previously showed that intravenous injection of rat anti-BSA-BSA complexes (IC) prepared in 5x antigen excess rapidly induced a striate pattern of serosal (to mucosal) hemorrhage and vascular congestion throughout the small intestine. In this study, we tested the effect of a BFD and FFD on immune complex-induced enteropathy. After six (Expt. 1) or eight weeks (Expt. 2) on the diet, rats were injected with IC and the severity of serosal hyperemia in the small intestine was scored. In some FFD, no lesions were seen under conditions which elicited moderate to severe lesions in BFD rats. In Expt. 1 involving 22 rats and in Expt. 2 involving 28 rats, those on the FFD had a significantly lower composite lesional score compared to those on the BFD, p less than 0.005 and p less than 0.005, respectively. These results indicate that the FFD had a beneficial effect on IC-induced enteropathy. It is suggested that this effect of the FFD may be mediated primarily by a reduction in availability of platelet-activating factor.


Assuntos
Gorduras na Dieta/farmacologia , Óleos de Peixe/farmacologia , Doenças do Complexo Imune/patologia , Enteropatias/patologia , Intestino Delgado/patologia , Animais , Bovinos , Ácidos Graxos/análise , Feminino , Doenças do Complexo Imune/metabolismo , Enteropatias/metabolismo , Ratos , Ratos Endogâmicos , Baço/análise
3.
Am J Pathol ; 115(3): 375-82, 1984 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6233906

RESUMO

Previously it was shown that tissue injury occurring in acute immune-complex-induced vasculitis, which is complement and neutrophil-dependent, is significantly attenuated by the presence of catalase, suggesting the pathogenic role of H2O2 generated from activated neutrophils. We now show that significant protection is also afforded by pretreatment of animals with apolactoferrin , a naturally occurring chelator of iron. Iron-saturated lactoferrin is devoid of protective effects. Deferoxamine mesylate, a synthetic iron chelator, also has protective effects. Infusion of ionic iron, especially Fe(III), potentiates the tissue injury. Significant protection from tissue injury is also produced by treatment of rats with dimethyl sulfoxide, a potent hydroxyl radical scavenger. Morphologically, animals treated with these protective interventions show the influx of neutrophils into sites of immune complex deposition, but there is markedly attenuated edema, little or no hemorrhage, and little evidence of endothelial cell injury, in contrast to the findings in nonprotected animals. These data support the suggestion that immune-complex-induced injury may be linked to generation of H2O2 from activated neutrophils and the subsequent conversion of H2O2 to the hydroxyl radical.


Assuntos
Doenças do Complexo Imune/etiologia , Vasculite/etiologia , Animais , Apoproteínas/uso terapêutico , Reação de Arthus/etiologia , Reação de Arthus/metabolismo , Reação de Arthus/patologia , Cloretos , Desferroxamina/uso terapêutico , Dimetil Sulfóxido/uso terapêutico , Avaliação Pré-Clínica de Medicamentos , Compostos Férricos/uso terapêutico , Compostos Ferrosos/uso terapêutico , Radicais Livres , Hidroxilação , Doenças do Complexo Imune/metabolismo , Doenças do Complexo Imune/patologia , Lactoferrina/uso terapêutico , Masculino , Compostos de Amônio Quaternário/uso terapêutico , Ratos , Ratos Endogâmicos , Organismos Livres de Patógenos Específicos , Vasculite/metabolismo , Vasculite/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA